awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30300234-5ECE5205-FA81-4C93-84D3-1EFE624B9C2A
Q30300234-5ECE5205-FA81-4C93-84D3-1EFE624B9C2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30300234-5ECE5205-FA81-4C93-84D3-1EFE624B9C2A
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
P2860
Q30300234-5ECE5205-FA81-4C93-84D3-1EFE624B9C2A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30300234-5ECE5205-FA81-4C93-84D3-1EFE624B9C2A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6015f77a6076821c49de48d7e33b2ba3a97a71bc
P2860
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.